Pathogenic autoantibodies in systemic sclerosis (SSc). | Download Table
Scleroderma – Symptoms and Causes | Penn Medicine
Labwork thoughts : r/scleroderma
Scleroderma | NEJM
Cells | Free Full-Text | Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis
Scleroderma - getting diagnosed | SRUK
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology
Scleroderma | NEJM
JCM | Free Full-Text | Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies | Semantic Scholar
Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease - Page 10 of 11 - The Rheumatologist
Tests for Autoimmune Diseases | Quest Diagnostics
![PDF] Differential Diagnosis Localized Scleroderma and Scleroderma-Like Disorders | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e4529adf01f18c968baa0a641d197cc5ef18615b/17-Table2-1.png "PDF] Differential Diagnosis Localized Scleroderma and Scleroderma-Like Disorders | Semantic Scholar")
PDF] Differential Diagnosis Localized Scleroderma and Scleroderma-Like Disorders | Semantic Scholar
Connective Tissue Diseases
The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology
Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells | Nature Medicine
Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma? - ScienceDirect
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets - ScienceDirect
False Positive Anti-Topoisomerase I (Scl-70) Antibody Results: A Case Series from a Scleroderma Referral Center - ACR Meeting Abstracts
Autoantibodies are present before the clinical diagnosis of systemic sclerosis | PLOS ONE
Scl-70 | Lab Tests Guide
Autoantibodies and Their Role in Scleroderma Clinical Care | Current Treatment Options in Rheumatology
Predicting the Progression of Very Early Systemic Sclerosis: Current I | OARRR
Scleroderma Antibodies and Clinical Relevance – Scleroderma Education Project
Tumor Necrosis Factor α Inhibitor–Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol | MDedge Dermatology
